The Great Pharmaceutical Gridlock: How Patents Keep Prices Sky-High and Biosimilars at Bay
A New Dawn for Cancer Care: FDA Taps Veteran Scientist Richard Pazdur to Lead Groundbreaking Initiative
Florida's Arthritis Patients Face a Looming Threat: Is Washington's Drug Pricing Plan Stifling the Hope for New Cures?
The Looming Storm: How Trade Tensions Could Reshape the World's Pharmacy
A Whisper Becomes a Roar: Unpacking the Turmoil at FDA's Biologics Hub
The Great Weigh-In: Pharma's Fierce Battle for the Future of Obesity, and What Else Keeps Them Up at Night
The Biologic Revolution: Unpacking the Promise and Price of Tomorrow's Cures
The Shifting Sands of Pharma: Why India's CDMOs Face a Defining Moment of Specialization
North Carolina's Biotech Boom: Powering the Future of Medicine Through Advanced Manufacturing
A New Chapter: Peter Marks, Former FDA Vaccine Czar, Lands at Eli Lilly
The Biotech & Pharma Services Market: A Decade of Explosive Growth Towards $130 Billion
Unlocking the Future of Medicine: Protein Expression Market Set for Explosive Growth to $6.60 Billion by 2032
Regeneron's Growth Horizon: Beyond the Core, Towards New Frontiers
South Korean Pharma Giant Celltrion Seals $330M Deal for Eli Lilly's U.S. Biologics Facility
Trump's Ambitious Drug Tax Plan: A High-Stakes Bet on American Healthcare
Cambrex Revolutionizes Peptide Manufacturing with Major Waltham Expansion